Inventor · disambiguated record
Øystein Rekdal
Also filed as: REKDAL OEYSTEIN · REKDAL ØYSTEIN
11 granted patents·2 pending applications·43 citations·filing 2000–2023
87Inventor score
Top patents by PatentIndex Score
13 records- 0188US9556223B2Antimicrobial compoundsSTENSEN WENCHE·Filed 2009·Granted Jan 31, 2017·14 cites·11 claims
- 0281US9085608B2Treatment of biofilmsSTENSEN WENCHE·Filed 2009·Granted Jul 21, 2015·12 cites·23 claims
- 0380US7232803B2Antimicrobial compounds and formulationsLYTIX BIOPHARMA AS·Filed 2001·Granted Jun 19, 2007·8 cites·9 claims
- 0476US8143211B2Bioactive peptidesSVENDSEN JOHN SIGURD·Filed 2008·Granted Mar 27, 2012·4 cites·14 claims
- 0569US8283315B2Inhibition of tumour growthELIASSEN LIV TONE·Filed 2007·Granted Oct 9, 2012·2 cites·18 claims
- 0666US8048852B2Antimicrobial compounds and formulationsLYTIX BIOPHARMA AS·Filed 2007·Granted Nov 1, 2011·0 cites·26 claims
- 0766US7439228B2Bioactive peptidesLYTIX BIOPHARMA AS·Filed 2001·Granted Oct 21, 2008·3 cites·8 claims
- 0866US2025002854A1Methods of generating populations of tumour-infiltrating t cellsLYTIX BIOPHARMA AS·Filed 2023·Application pending·0 cites
- 0953US9115169B2Method of treating tumorsSVENDSEN JOHN SIGURD·Filed 2011·Granted Aug 25, 2015·0 cites·6 claims
- 1053US9109048B2Inhibition of tumor growthELIASSEN LIV TONE·Filed 2012·Granted Aug 18, 2015·0 cites·18 claims
- 1150US2019038670A1Methods of generating populations of tumour-infiltrating t cellsLYTIX BIOPHARMA AS·Filed 2017·Application pending·0 cites
- 1235US10287320B2Anti-lymphoma peptidesUNIV I TROMSOE—NORGES ARKTISKE UNIV·Filed 2015·Granted May 14, 2019·0 cites·7 claims
- 1326US7393824B1Methods of peptide preparationLYTIX BIOPHARMA·Filed 2000·Granted Jul 1, 2008·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Øystein Rekdal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →